CTLA4 and infection: We performed two experimental approaches: (i) preventive CTLA-4-Ig treatment, starting at week 4 after infection and (ii) therapeutic CTLA-4-Ig treatment starting at week 8 after infection to investigate the therapeutic potency of CTLA-4-Ig in counteracting the profibrotic immune reactions.